methionine has been researched along with oxidopamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elkon, H; Melamed, E; Offen, D | 1 |
| Gajbhiye, S; Jalgaonkar, S; Khatri, N; Parmar, U; Sayyed, M; Shankar, A; Tripathi, R | 1 |
2 other study(ies) available for methionine and oxidopamine
| Article | Year |
|---|---|
6-Hydroxydopamine increases ubiquitin-conjugates and protein degradation: implications for the pathogenesis of Parkinson's disease.
Topics: Acetylcysteine; Animals; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Dose-Response Relationship, Drug; Free Radical Scavengers; Humans; Leupeptins; Lewy Bodies; Methionine; Models, Neurological; Multienzyme Complexes; Nerve Tissue Proteins; Neurons; Oxidopamine; Parkinson Disease; PC12 Cells; Proteasome Endopeptidase Complex; Rats; Substantia Nigra; Sulfur Radioisotopes; Sympatholytics; Ubiquitins | 2001 |
S-adenosyl methionine improves motor co-ordination with reduced oxidative stress, dopaminergic neuronal loss, and DNA methylation in the brain striatum of 6-hydroxydopamine-induced neurodegeneration in rats.
Topics: Animals; Antioxidants; Brain; Disease Models, Animal; DNA Methylation; Dopamine; Glutathione; Methionine; Neurodegenerative Diseases; Neuroprotective Agents; Oxidative Stress; Oxidopamine; Parkinson Disease; Rats; Substantia Nigra | 2023 |